In addition, the study aims to evaluate the therapeutic virtue of the optimized RES-loaded bilosomes in the treatment of Alzheimer’s disease in a mice model by studying the levels of oxidative stress biomarkers, amyloid-beta peptide and Tau protein levels, besides the histological examination, immuno-histochemical analysis and behavioral assessment. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.